Zhang et al. BMC Cancer 2011, 11:32 http://www.biomedcentral.com/1471-2407/11/32 in cell growth, malignant transformation and drug resistance. BBA-Mol Cancer Res 2007, 1773:1263-1284. 23. Syed Z, Cheepala SB, Gill JN, Stein J, Nathan CA, Digiovanni J, Batra V, Adegboyega P, Kleiner HE, Clifford JL: All-trans retinoic acid suppresses Stat3 signaling during skin carcinogenesis. Cancer Prev Res 2009, 2:903-911. 24. Yuan ZL, Guan YJ, Wang L, Wei W, Kane AB, Chin YE: Central role of the threonine residue within the p+1 loop of receptor tyrosine kinase in STAT3 constitutive phosphorylation in metastatic cancer cells. Mol Cell Biol 2004, 24:9390-9400. 25. Silva CM: Role of STATs as downstream signal transducers in Src family kinase-mediated tumorigenesis. Oncogene 2004, 23:8017-8023. 26. Alexandropoulos K, Cheng G, Baltimore D: Proline-rich sequences that bind to Src homology 3 domains with individual specificities. Proc Natl Acad Sci USA 1995, 92:3110-3114. 27. Sahai E, Marshall CJ: RHO-GTPases and cancer. Nat Rev Cancer 2002, 2:133-142. 28. Vial E, Sahai E, Marshall CJ: ERK-MAPK signaling coordinately regulates activity of Rac1 and RhoA for tumor cell motility. Cancer Cell 2003, 4:67-79. 29. Gomez del Pulgar T, Benitah SA, Valeron PF, Espina C, Lacal JC: Rho GTPase expression in tumorigenesis: evidence for a significant link. Bioessays 2005, 27:602-613. 30. Sahai E, Marshall CJ: Differing modes of tumor cell invasion have distinct requirements for Rho/ROCK signaling and extracellular proteolysis. Nat Cell Biol 2003, 5:711-719. 31. Yoshioka K, Nakamori S, Itoh K: Overexpression of small GTP-binding protein RhoA promotes invasion of tumor cells. Cancer Res 1999, 59:2004-2010. Pre-publication history The pre-publication history for this paper can be accessed here: http://www.biomedcentral.com/1471-2407/11/32/prepub doi:10.1186/1471-2407-11-32 Cite this article as: Zhang et al.: Tumor-suppressor activity of RRIG1 in breast cancer. BMC Cancer 2011 11:32. Page 12 of 12 Submit your next manuscript to BioMed Central and take full advantage of: • Convenient online submission • Thorough peer review • No space constraints or color ﬁgure charges • Immediate publication on acceptance • Inclusion in PubMed, CAS, Scopus and Google Scholar • Research which is freely available for redistribution Submit your manuscript at www.biomedcentral.com/submit